The Oklahoma House of Representatives recently passed House Bill 2728, a measure designed to enhance transparency and ...

Lynn Dekleva, who recently took a senior role at the agency, once led an aggressive effort by industry to block regulations ...

Insmed Incorporated (NASDAQ: INSM) announced on February 24, 2025 that the U.S. Food and Drug Administration (FDA) does not ...

The FDA granted priority review to pembrolizumab for neoadjuvant and adjuvant use in head and neck squamous cell carcinoma, ...

The FDA accepted for priority review a supplemental Biologics License Application for Keytruda for resectable locally ...

It won’t happen until after the quarterback position is resolved. It might not transpire until late in training camp or a few ...

ZenBusiness is a business formation service that will help you file the paperwork for registering a business entity as either ...

The $149 Satechi 6-Port Charging Station can output 200W over multiple USB-C ports, although not as intelligently as the ...

Precigen on Tuesday said a green light would make PRGN-2012 the only FDA-approved therapeutic for the treatment of adults with the disorder, which is a lifelong neoplastic disease of the upper and ...

Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its blockbuster cancer drug Keytruda in certain patients with head and neck cancer.

Morgantown’s Civilian Police Review and Advisory Board has set a review of the Morgantown Police Department’s officer-worn ...

Zongertinib, an investigational treatment for HER2-mutant advanced NSCLC, has received FDA priority review, showing positive ...